Ain Holdings Inc. · TSE:9627
Ain — Q3 FY4/19 Earnings Presentation
25 slides from Ain's earnings presentation, March 2019
Slide 1: FY4/19 3Q IR Presentation
FY4/19 3Q IR PRESENTATION March 2019
Slide 2: Results Overview
Results Overview © 2019 AIN HOLDINGS INC. All Rights Reserved. 1
Slide 3: Consolidated P/L
Consolidated P/L Net sales increased 1.2% year on year to ¥202,522 million, operating income declined 16.8% to ¥11,909 million, ordinary income dropped 15.8% to ¥12,425 million, and profit attributable to owners of parent decreased 14.5% to ¥6,781 million. FY4/18 3Q FY4/19 3Q FY4/19 3Q YoY YoY Vs pl
Slide 4: Dispensing Pharmacy Business (Consolidated)
Dispensing Pharmacy Business (Consolidated) Net sales increased 0.7% year on year and 0.7% against the plan due to the drug price that exceed the expectation and stores opened in the previous fiscal year made a significant contribution to sales. Segment income decreased 5.3% against the plan due to
Slide 5: Cosmetic and Drug Store Business (Consolidated)
Cosmetic and Drug Store Business (Consolidated) Although the net sales of existing stores has showing steadily growth, net sales increased 6.5 % year on year and decreased 6.0% against the plan due to the series of natural disaster. Segment income decreased 9.1% against the plan due to net sales una
Slide 6: Consolidated B/S
Consolidated B/S Net cash was ¥38,696 million and shareholders’ equity ratio became 55.5%. We are maintaining a sound financial structure. (¥ million) (¥ million) End-FY4/18 End-FY4/19 3Q Assets Liabilities Assets Liabilities Current assets 69,950 Current assets 69,235 94,557 Current liabilities 88,
Slide 7: Assets
Assets The balance of total assets decreased ¥351 million from the end of the previous fiscal year due to the decrease of cash on hand and in banks while inventories has increased. (¥ million) End-FY4/18 3Q End-FY4/18 End-FY4/19 3Q Change Cash on hand and in banks 60,572 63,779 53,494 (10,285) Repay
Slide 8: Liabilities and Net Assets
Liabilities and Net Assets The balance of liabilities decreased ¥5,292 million from the end of the previous fiscal year due to the repayment of debts etc. (¥ million) End-FY4/18 3Q End-FY4/18 End-FY4/19 3Q Change Accounts payable 41,351 38,728 43,016 +4,288 Short-term debt 8,207 6,717 6,935 +218 Lea
Slide 9: FY4/19 Plan (Consolidated)
FY4/19 Plan (Consolidated) The group forecasts net sales for the fiscal year ending April 30, 2019 of 272,870 million, increase 1.7% year on year by openings new stores (100 pharmacies and 7 Cosmetic and drug stores) , ordinary income decrease 10.6% due to the dispensing fee revisions. FY4/17 FY4/18
Slide 10: 3Q Review
3Q Review © 2019 AIN HOLDINGS INC. All Rights Reserved. 9
Slide 11: Review① (YoY)
Review①（YoY） ■ Net sales FY4/18 3Q FY4/19 3Q YoY YoY +¥6.8 ¥(6.7) results results change change (%) billion billion New stores Existing stores, (¥ million) Impact of revision ¥(2.5) Net sales 200,043 202,522 2,479 +1.2 +¥4.9 billion billion Close of Full contribution of store ¥2.5 unprofitable Gross
Slide 12: Review② (Vs plan)
Review②（Vs plan） ■ Net sales ¥(1.4) FY4/19 3Q FY4/19 3Q Vs plan billion Vs plan +¥1.6 New store plan results (%) billion openings lag (¥ million) existing behind stores, etc. schedule Net sales 202,890 202,522 (368) (0.2) ¥(0.5) FY4/19 3Q results billion FY4/19 3Q Close of ¥(0.3) Gross profit % of n
Slide 13: Response to revision of 2018 premiums
Response to revision of 2018 Object: 988 stores, which including existing stores and stores opening in FY4/18 Basic dispensing fee Community support system premiums 1 (41 pts) 2 (25 pts) No premiums Community support system 4 stores which are other 3-Ⅱ (15 pts) S (10 pts) than Basic dispensing f
Slide 14: Top-line: store openings and M&A
Top-line The group has achieved the initial plan of M&A in end of the third quarter. Total number of store opening in end-FY4/19 will greatly exceeds the initial plan since the group is intend to acquire TSUCHIYA YAKUHIN INC. on March 28, 2019, which operates 36 dispensing pharmacies in Nagano Prefe
Slide 15: FY4/19 Plan (Dispensing Pharmacy Business)
FY4/19 Plan（Dispensing Pharmacy Business） ■ Net sales YoY +¥12.1 FY4/18 FY4/19 YoY billion ¥(11.9) change billion results plan change New 100 (%) Impact of （¥ million） store revision Net sales 238,645 239,800 +1,155 +0.5 ¥(4.0) billion Store Closing in current and previous year +¥4.9 billion Gross p
Slide 16: Expansion of AINZ & TULPE
Expansion of AINZ & TULPE ABENO HOOP Location Abeno-ku, Osaka Open Apr 10, 2019 (plan) Sales floor 301㎡ UMEDA HEPFIVE Location Kita-ku, Osaka Open Apr 19, 2019 (plan) Sales floor 566㎡ © 2019 AIN HOLDINGS INC. All Rights Reserved. 15
Slide 17: Expansion of AINZ & TULPE
Expansion of AINZ & TULPE Year FY 4/00 FY 4/02 FY 4/04 FY 4/06 FY 4/08 FY 4/10 FY 4/12 FY 4/14 FY 4/16 FY 4/18 FY 4/20 FY 4/22 Open department Renewal of Complex facility First ainz & tulpe store SAPPORO CHIKAGAI Expanded Flagship store in Open store Nationwide metropolitan area Strategy inside the
Slide 18: FY4/19 Plan (Cosmetic and Drug Store Business)
FY4/19 Plan（Cosmetic and Drug Store Business） ■ Net sales +¥1.2 billion YoY New 7 ¥(0.7) billion FY4/18 FY4/19 YoY stores change Closed in previous year stores results plan change (%) （¥ million） +¥0.7 billion Full contribution of +¥2.8 opening in previous year Net sales 24,117 27,000 +2,883 +12.0 B
Slide 19: FY4/19 Plan (Consolidated)
FY4/19 Plan (Consolidated) The group forecasts net sales for the fiscal year ending April 30, 2019 of 272,870 million, increase 1.7% year on year by openings new stores (100 pharmacies and 7 Cosmetic and drug stores) , ordinary income decrease 10.6% due to the dispensing fee revisions. FY4/17 FY4/18
Slide 20: Supplementary Information
Supplementary Information © 2019 AIN HOLDINGS INC. All Rights Reserved. 19
Slide 21: Dispensing Fee Revisions of 2018
Dispensing Fee Revisions of 2018 Basic dispensing fee（New classification requirements ） 1 41 pts 2 25 pts Over 4,000 times & 70% or Over 2,000 times & Over 85% or Over 4,000 times from specific hospital 3-Ⅰ 20 pts Same group over 40,000 times / month & Over 85% or lease contract with medical insti
Slide 22: Company Profile
Company Profile Trade name AIN HOLDINGS INC Representative Kiichi Otani, President and Representative Director Established August 1969 Market capitalization ¥274,214 million As of Mar 4, 2019 Net sales and Net sales: ¥268,385 million Operating income: ¥19,622 million As of FY4/18 operating income Di
Slide 23: Comparison to Other Companies
Comparison to Other Companies （%） 8.0 7.0 B company 6.0 C company AIN HOLDINGS Net sales：¥268,385 million Operating margin E company 5.0 A company Operating margin：7.3% Market capitalization： 4.0 D company ¥274,214 million 3.0 2.0 1.0 0.0 0 40,000 80,000 120,000 160,000 200,000 240,000 280,000 （¥ mi
Slide 24: Inquiries
Inquiries related to this presentation should be addressed to AIN HOLDINGS INC. Corporate Planning Division TEL(81)11-814-0010 FAX(81)11-814-5550 http://www.ainj.co.jp/ This document may not be reproduced or distributed to any third party without prior approval of AIN HOLDINGS INC. This document has
Slide 25: AIN GROUP
AIN GROUP